An FDA advisory panel is meeting once again on Friday, this time to decide whether or not to add Johnson & Johnson to the list of approved COVID-19 vaccine booster shots.
An FDA advisory panel is meeting once again on Friday, this time to decide whether or not to add Johnson & Johnson to the list of approved COVID-19 vaccine booster shots.
FDA panel unanimously votes to recommend Pfizer vaccine for kids as young as 5